feedback

Course Directors

Stephen J. Nicholls, MBBS, PhD
Stephen J. Nicholls, MBBS, PhD

University of Adelaide
Royal Adelaide Hospital
Adelaide, Australia

Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC
Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC

Harvard Medical School
Brigham and Women’s Hospital Heart & Vascular Center
Boston, Massachusetts, USA

Faculty

Christie M. Ballantyne
Christie M. Ballantyne, MD, FACC, FAHA, FNLA

Baylor College of Medicine
Houston Methodist DeBakey Heart and Vascular Center
Houston, Texas, USA

Accredited by

Oakstone Publishing, LLC

Activity Details

Credit Types:CME
Credit Amount:1.0 Credits
Release Date:2016-Sep-30
Expiration Date:2017-Sep-29
Estimated Time for Completion:60 minutes
Registration Required:No
Cost:Free of Charge

Funding Disclosure

This activity is supported by an educational grant from Amgen.

Activity Description & Educational Objectives

In this activity, based on a symposium held on August 27, 2016, experts in cardiovascular medicine discuss the management of patients with coronary atherosclerosis, particularly those with plaque burden.

Upon completion of this activity, participants should be better able to:

  • Assess the current strategies to optimise detection and management of patients with coronary atherosclerosis
  • Evaluate the impact of aggressive strategies to lower LDL-C on plaque regression and patient outcomes, based on available clinical data
  • Identify clinical opportunities to reduce residual cardiovascular risk in patients with coronary atherosclerosis using available treatment strategies

Target Audience

This activity has been designed to meet the educational needs of cardiologists, lipidologists, and other clinicians involved in the management of patients with coronary atherosclerosis.

Faculty & Disclosure / Conflict of Interest Policy

Oakstone Publishing, LLC has assessed conflict of interest with its faculty, authors, editors, and any individuals who were in a position to control the content of this CME activity. Any identified relevant conflicts of interest were resolved for fair balance and scientific objectivity of studies utilized in this activity. Oakstone Publishing’s planners, medical reviewers, and editorial staff disclose no relevant financial relationships with commercial interests.

Course Directors and Interviewees

Stephen J. Nicholls, MBBS, PhD
Deputy Director and Heart Health Theme Leader, South Australian Health & Medical Research Institute (SAHMRI)
Principal Research Fellow, National Health and Medical Research Council (NHMRC)
Professor of Cardiology, University of Adelaide
Cardiologist, Royal Adelaide Hospital
Adelaide, Australia

Stephen J. Nicholls, MBBS, PhD, has a financial interest/relationship or affiliation in the form of:

Consultant for Amgen Inc; AstraZeneca; CSL Limited; Eli Lilly and Company; Merck and Company; Sanofi; and Takeda Pharmaceutical Company Limited.

Grant/Research Support from Amgen Inc; AstraZeneca; Cerenis Therapeutics Holding; Eli Lilly and Company; The Medicines Company; Novartis International AG; and Sanofi.

Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC
Professor of Medicine, Harvard Medical School
Executive Director of Interventional Cardiovascular Programs,
Brigham and Women’s Hospital Heart & Vascular Center
Boston, Massachusetts, USA

Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC, has a financial interest/relationship or affiliation in the form of:

Grant/Research Support from Amarin Corporation Plc; Amgen; AstraZeneca Plc; Bristol-Myers Squibb; Eisai Company Limited; Ethicon Inc; Forest Laboratories LLC; Ischemix Inc; Medtronic Ltd; Pfizer Inc; Roche AG; Sanofi Aventis; and The Medicines Company.

Interviewee

Christie M. Ballantyne, MD, FACC, FAHA, FNLA
Professor of Medicine
Chief, Section of Cardiology
Chief, Section of Cardiovascular Research
Baylor College of Medicine
Director, Center for Cardiovascular Disease Prevention
Houston Methodist DeBakey Heart and Vascular Center
Houston, Texas, USA

Christie M. Ballantyne, MD, FACC, FAHA, FNLA, has a financial interest/relationship or affiliation in the form of:

Consultant for Abbott Diagnostic; Amarin Corporation plc; Amgen; Astra Zeneca Plc; Eli Lilly and Company; Esperion Therapeutics Inc; Genzyme Corporation; Ionis Pharmaceuticals; Matinas BioPharma Holdings Inc; Merck and Company; Novartis; Pfizer; Regeneron Pharmaceuticals, Inc; Roche Diagnostic; and Sanofi-Synthelabo.

Grant/Research Support from Abbott Diagnostic; American Diabetes Association; American Heart Association; Amarin Corporation plc; Amgen; Eli Lilly and Company; Esperion Therapeutics Inc; National Institute of Health; Novartis Pharmaceutical Company; Otsuka Pharmaceutical; Pfizer Inc; Regeneron Pharmaceuticals Inc; Roche Diagnostic; Sanofi-Synthelabo; and Takeda Pharmaceutical Company Limited.

Medical Director

Serena Welch
PeerVoice

Serena Welch has no financial interests/relationships or affiliations in relation to this activity.

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labelled for use in certain jurisdictions. Faculty members have been advised to disclose to the audience any reference to an unlabelled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our materials. No responsibility is taken for errors or omissions in our materials.

Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Oakstone Publishing, LLC and PeerVoice. Oakstone Publishing, LLC is accredited by the ACCME to provide continuing medical education for physicians.

Oakstone Publishing, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The ACCME and the European Board of Accreditation in Cardiology (EBAC) recognise each other’s accreditation systems as substantially equivalent. To obtain EBAC credit for participation in this activity, submit evidence of participation directly to EBAC (www.ebac-cme.org).

The European Union of Medical Specialists (UEMS)-European Accreditation Council for Continuing Medical Education (EACCME) has an agreement of mutual recognition of continuing medical education (CME) credit with the American Medical Association (AMA). European physicians interested in converting AMA PRA Category 1 Credit™ into European CME credit (ECMEC) should contact the UEMS (www.uems.eu).

This CME activity is jointly provided by Oakstone Publishing, LLC and PeerVoice.

Requirements for Successful Completion

To receive credit, participants must complete the activity, the post-test, and the evaluation form prior to the expiration date noted below. There are no pre-requisites and there is no fee to participate in this activity or to receive credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form. Consult your professional licensing board for information about your eligibility to claim credit for participation in this educational activity. A minimum performance level of 70% is needed.

Media: Internet
Release and Expiration Dates: September 30, 2016 - September 29, 2017
Time to Complete: 60 minutes

Disclaimer

The participants of this educational activity have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

*PeerCME is an independent publisher of conference news and medical education programmes.

The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of PeerVoice or any of its supporters.

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.